These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 35460276

  • 1. Intestinal peroxisome proliferator-activated receptor α-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis.
    Yan T, Luo Y, Yan N, Hamada K, Zhao N, Xia Y, Wang P, Zhao C, Qi D, Yang S, Sun L, Cai J, Wang Q, Jiang C, Gavrilova O, Krausz KW, Patel DP, Yu X, Wu X, Hao H, Liu W, Qu A, Gonzalez FJ.
    Hepatology; 2023 Jan 01; 77(1):239-255. PubMed ID: 35460276
    [Abstract] [Full Text] [Related]

  • 2. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.
    Lee H, Ahn J, Shin SS, Yoon M.
    Int J Obes (Lond); 2019 Aug 01; 43(8):1620-1630. PubMed ID: 30283077
    [Abstract] [Full Text] [Related]

  • 3. Diethyldithiocarbamate inhibits the activation of hepatic stellate cells via PPARα/FABP1 in mice with non-alcoholic steatohepatitis.
    Sun X, Yu Q, Kang B, Zhao X, Li H, Liu H, Liu L, Wang P, Cong M, Liu T.
    Biochem Biophys Res Commun; 2023 Jan 22; 641():192-199. PubMed ID: 36535078
    [Abstract] [Full Text] [Related]

  • 4. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH, Chen TH, Lee BH, Hsu YW, Pan TM.
    Food Chem Toxicol; 2014 Feb 22; 64():94-103. PubMed ID: 24275089
    [Abstract] [Full Text] [Related]

  • 5. A novel fatty acid mimetic with pan-PPAR partial agonist activity inhibits diet-induced obesity and metabolic dysfunction-associated steatotic liver disease.
    Sahin C, Melanson JR, Le Billan F, Magomedova L, Ferreira TAM, Oliveira AS, Pollock-Tahari E, Saikali MF, Cash SB, Woo M, Romeiro LAS, Cummins CL.
    Mol Metab; 2024 Jul 22; 85():101958. PubMed ID: 38763495
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A novel Alisma orientale extract alleviates non-alcoholic steatohepatitis in mice via modulation of PPARα signaling pathway.
    Xie Y, Jin Y, Wen J, Li G, Huai X, Duan Y, Ni F, Fu J, Li M, Li L, Yan M, Cao L, Xiao W, Yang H, Wang ZZ.
    Biomed Pharmacother; 2024 Jul 22; 176():116908. PubMed ID: 38850668
    [Abstract] [Full Text] [Related]

  • 8. Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity.
    Stec DE, Gordon DM, Hipp JA, Hong S, Mitchell ZL, Franco NR, Robison JW, Anderson CD, Stec DF, Hinds TD.
    Am J Physiol Regul Integr Comp Physiol; 2019 Nov 01; 317(5):R733-R745. PubMed ID: 31483154
    [Abstract] [Full Text] [Related]

  • 9. Oleuropein mitigates non-alcoholic fatty liver disease (NAFLD) and modulates liver metabolites in high-fat diet-induced obese mice via activating PPARα.
    Zhou W, Du Z.
    J Sci Food Agric; 2024 Nov 01; 104(14):8634-8645. PubMed ID: 38952322
    [Abstract] [Full Text] [Related]

  • 10. PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease.
    Huang K, Du M, Tan X, Yang L, Li X, Jiang Y, Wang C, Zhang F, Zhu F, Cheng M, Yang Q, Yu L, Wang L, Huang D, Huang K.
    J Hepatol; 2017 May 01; 66(5):962-977. PubMed ID: 27979751
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function.
    Zhang J, Zhang W, Yang L, Zhao W, Liu Z, Wang E, Wang J.
    Phytomedicine; 2023 Jan 01; 109():154589. PubMed ID: 36610145
    [Abstract] [Full Text] [Related]

  • 13. Folic acid attenuates high-fat diet-induced steatohepatitis via deacetylase SIRT1-dependent restoration of PPARα.
    Xin FZ, Zhao ZH, Zhang RN, Pan Q, Gong ZZ, Sun C, Fan JG.
    World J Gastroenterol; 2020 May 14; 26(18):2203-2220. PubMed ID: 32476787
    [Abstract] [Full Text] [Related]

  • 14. The role of mouse and human peroxisome proliferator-activated receptor-α in modulating the hepatic effects of perfluorooctane sulfonate in mice.
    Su S, Billy LJ, Chang S, Gonzalez FJ, Patterson AD, Peters JM.
    Toxicology; 2022 Jan 15; 465():153056. PubMed ID: 34861291
    [Abstract] [Full Text] [Related]

  • 15. Modulation of fatty acid and bile acid metabolism by peroxisome proliferator-activated receptor α protects against alcoholic liver disease.
    Li HH, Tyburski JB, Wang YW, Strawn S, Moon BH, Kallakury BV, Gonzalez FJ, Fornace AJ.
    Alcohol Clin Exp Res; 2014 Jun 15; 38(6):1520-31. PubMed ID: 24773203
    [Abstract] [Full Text] [Related]

  • 16. Selective peroxisome proliferator-activated receptor-α modulator K-877 efficiently activates the peroxisome proliferator-activated receptor-α pathway and improves lipid metabolism in mice.
    Takei K, Han SI, Murayama Y, Satoh A, Oikawa F, Ohno H, Osaki Y, Matsuzaka T, Sekiya M, Iwasaki H, Yatoh S, Yahagi N, Suzuki H, Yamada N, Nakagawa Y, Shimano H.
    J Diabetes Investig; 2017 Jul 15; 8(4):446-452. PubMed ID: 28084058
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
    Yang RX, Pan Q, Liu XL, Zhou D, Xin FZ, Zhao ZH, Zhang RN, Zeng J, Qiao L, Hu CX, Xu GW, Fan JG.
    Lipids Health Dis; 2019 Oct 21; 18(1):179. PubMed ID: 31639005
    [Abstract] [Full Text] [Related]

  • 18. Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity.
    Régnier M, Polizzi A, Smati S, Lukowicz C, Fougerat A, Lippi Y, Fouché E, Lasserre F, Naylies C, Bétoulières C, Barquissau V, Mouisel E, Bertrand-Michel J, Batut A, Saati TA, Canlet C, Tremblay-Franco M, Ellero-Simatos S, Langin D, Postic C, Wahli W, Loiseau N, Guillou H, Montagner A.
    Sci Rep; 2020 Apr 16; 10(1):6489. PubMed ID: 32300166
    [Abstract] [Full Text] [Related]

  • 19. PRDX6 Promotes Fatty Acid Oxidation via PLA2-Dependent PPARα Activation in Rats Fed High-Fat Diet.
    Shen W, Yang L, Yang Y, Wang P, Tao X, Shen Y, Wang S, Shen Y.
    Antioxid Redox Signal; 2023 Jun 16; 38(16-18):1184-1200. PubMed ID: 36401357
    [Abstract] [Full Text] [Related]

  • 20. PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver.
    Abdelmegeed MA, Yoo SH, Henderson LE, Gonzalez FJ, Woodcroft KJ, Song BJ.
    J Nutr; 2011 Apr 01; 141(4):603-10. PubMed ID: 21346097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.